4.7 Article

Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome

Journal

BLOOD
Volume 139, Issue 13, Pages 2038-2049

Publisher

AMER SOC HEMATOLOGY

Keywords

-

Categories

Funding

  1. National Institutes of Health (NIH) National Heart, Blood, and Lung Institute (NHLBI) [R01 HL151651]
  2. Edward P. Evans Foundation
  3. NIH New Innovator Award [DP2 HL147126]
  4. NIH NHLBI [R01 HL128239, R21 HL139864]
  5. Wayne D. Kuni and Joan E. Kuni Foundation
  6. American Society of Hematology Scholar Award
  7. NIH National Cancer Institute [R01 CA251138]
  8. NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK103854]
  9. Blood Cancer Discoveries Grant program through the Leukemia & Lymphoma Society
  10. Mark Foundation for Cancer Research
  11. Paul G. Allen Frontiers Group [8023-20]
  12. Leukemia & Lymphoma Society [1344-18]
  13. McIlwain Family Endowed Chair in Data Science
  14. Fred Hutchinson Cancer Research Center's Scientific Computing Infrastructure (Office of Research Infrastructure Programs grant) [S10 OD028685]
  15. NIH NCI (Cancer Center Support Grant) [P30 CA015704]
  16. Seattle Translational Tumor Research grant
  17. National Research Foundation of Korea (NRF) - Korean government [NRF-2018R1A6A1A03025810, NRF-2020R1A2C2012878]
  18. Institute for Stem Cell and Regenerative Medicine fellowship

Ask authors/readers for more resources

SF3B1 splicing factor mutations are a major cause of ring sideroblasts (RS) formation in myelodysplastic syndromes (MDS). In this study, an induced pluripotent stem cell model of SF3B1-mutant MDS was established, successfully recapitulating RS formation. Mutant SF3B1 induces missplicing of mitochondrial transporters TMEM14C and ABCB7, sequestering iron in mitochondria and causing RS formation.
SF3B1 splicing factor mutations are near-universally found in myelodysplastic syndromes (MDS) with ring sideroblasts (RS), a clonal hematopoietic disorder characterized by abnormal erythroid cells with iron-loaded mitochondria. Despite this remarkably strong genotype-to-phenotype correlation, the mechanism by which mutant SF3B1 dysregulates iron metabolism to cause RS remains unclear due to an absence of physiological models of RS formation. Here, we report an induced pluripotent stem cell model of SF3B1-mutant MDS that for the first time recapitulates robust RS formation during in vitro erythroid differentiation. Mutant SF3B1 induces missplicing of similar to 100 genes throughout erythroid differentiation, including proposed RS driver genes TMEM14C, PPOX, and ABCB7. All 3 missplicing events reduce protein expression, notably occurring via 59 UTR alteration, and reduced translation efficiency for TMEM14C. Functional rescue of TMEM14C and ABCB7, but not the non-rate-limiting enzyme PPOX, markedly decreased RS, and their combined rescue nearly abolished RS formation. Our study demonstrates that coordinated missplicing of mitochondrial transporters TMEM14C and ABCB7 by mutant SF3B1 sequesters iron in mitochondria, causing RS formation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available